DAFTAR PUSTAKA

Arief, M. I., Novriansyah, R., Budianto, I. T., Harmaji, M. B. (2012). Potensi

Bunga Karamunting (Melastoma malabathricum L.) terhadap Kadar
Kolesterol Total dan Trigliserida pada Tikus Putih Jantan Hiperlipidemia yang
Diinduksi Propiltiourasil. Jurnal Ilmiah Prestasi.
Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ,
2014. Primary prevention of cardiovascular disease with atorvastatin in type 2
diabetes in the Collaborative Ator vastatin Diabetes Study (CARDS)
multicentre randomizedplacebo controlled trial. Lancet 2014;364:685‐96.
Gitawati, R., Widowati, L., & Suharyanto, F. (2015). Penggunaan Jamu pada Pasien
Hiperlipidemia Berdasarkan Data Rekam Medik, di Beberapa Fasilitas Pelayanan
Kesehatan di Indonesia. Jurnal Kefarmasian Indonesia, 5(1), 41–48
Herlina., Harijono., Achmad Subagio., Teti Estiasih.2013. Potensi Hipolipidemik Polisakarida
Larut Air Umbi Gembili (Dioscorea esculenta L.) pada Tikus Hiperlipidemia.
AGRITECH. 33(1).
Hervás Martinez-, S., Real, J.T., Priego, A., Sanz, J., Martín, J.M., Carmena, R., and Ascaso,
J.F. (2016). Hiperlipidemia familiar combinada, síndrome metabólico y enfermedad
cardiovascular. Revista Espanola de Cardiologia 59, 1195–1198.
Johnson IT, GR Fenwick. 2000. Dietary Anticarcinogen and Antimutagens. The royal Society
of Chemistry
Murray K.R., Granner D.R., & Rodwell V.W. (2006). Biokimia Harper (Edisi 27).
Jakarta : Penerbit Buku Kedokteran EGC, 217-241.

Rizqi, Afrida Wira Surya., Subrata Tri Widada., M. Atik Mar tsiningsih. 2014.
Pengaruh Pemberian Jus Buah Naga Merah (Hylocereus polyrhizus) Terhadap Kadar
Trigliserida Tikus Putih (Rattus norvegicus) Hiperlipidemia. Jurnal Teknologi
Laboratorium. 3(2)
Sánchez J. Merino., V.F. Gil Guillén. 2014. Hiperlipidemias. Medicine 2004; 9(23): 1512-1526
.
Taylor AJ, Sullenberger LE, Lee HJ, Lee JK, Grace KA. 2014. Arterial Biology for the
Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double
blind, placebo controlled study of extended release niacin on atherosclerosis
progression in secondary prevention patients treated with statins. Circulation 110:3512
7.